Estimates Revisions IXICO plc

Equities

Delayed London S.E. Other stock markets 03:02:20 2026-05-19 EDT			5-day change	1st Jan Change
7.400 ^GBX	+9.63%		+9.63%	-37.02%

02:41am	Ixico remains focused on delivering on guidance of 15% revenue growth for full year	RE
02:02am	Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	IXICO PLC
	LONZA GROUP AG
	BEONE MEDICINES AG
	REVOLUTION MEDICINES, INC.
	IQVIA HOLDINGS INC.
	CELLTRION, INC.
	ASCENDIS PHARMA A/S			-
	IONIS PHARMACEUTICALS, INC.
	EUROFINS SCIENTIFIC SE
	Average
	Weighted average by Cap.